Patent details

92366 Product Name: "Teriflunomide, son stéréoisomère et leurs sels pharmaceutiquement acceptables"

Basic Information

Publication number:
92366
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP027639624
Legal Status:
Active
Application number:
92366
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/13/838/001-005 - AUBAGIO - teriflunomide
Marketing Authorization Type:
Marketing Authorization Date:
26/08/2013
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
29/01/2014
First Marketing Authorization date:
26/08/2013
Grant date:
31/03/2014
Activation date:
04/04/2022
Publication date:
31/03/2014
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
04/04/2027
SPC Extension Expiration:
04/04/2027
Rejection date:
Withdrawal date:

Owner

From:
07/05/2019
 
 

Name:
Sanofi-Aventis Deutschland GmbH
Address:
Brüningstrasse 50, 65929 Frankfurt am Main, Germany (DE)

History of Owners

From:
20/07/2016
To:
07/05/2019

Name:
AVENTISUB LLC
Address:
3711 KENNETT PIKE, SUITE 200, GREENVILLE, DELAWARE 19807, United States (US)

From:
29/01/2014
To:
19/07/2016

Name:
Aventis Pharmaceuticals Inc.
Address:
55 Corporate Drive, Bridgewater, NJ 08807, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
29/01/2014
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
WETTSTEIN Joseph
Address:
United States (US)

Publication

Bulletin

1

Bulletin Heading:
CO
Bulletin edition number:
2019/07
Publication date:
11/06/2019
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:
SPC3
Bulletin edition number:
2025/04
Publication date:
04/03/2025
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20190000184A
Date Registered:
07/05/2019
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
MARKS & CLERK LLP
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Sanofi-Aventis Deutschland GmbH
Address:
Brüningstrasse 50, 65929 Frankfurt am Main, Germany (DE)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
30/04/2026
Annual Fee Number:
25
Annual Fee Amount:
450 Euro
Expected Payer:
Last Annual Fee Payment Date:
26/03/2025
Last Annual Fee Paid Number:
24
Last Annual Fee Paid Amount:
440 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
07/05/2019 Request For Change 5
07/05/2019 Outgoing Correspondence 1